LONDON, Nov. 2, 2017 /PRNewswire/ -- Europe IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023Download the full report: https://www.reportbuyer.com/product/5139380In vitro diagnostic is a non-invasive technique utilized in early diagnosis and management of diseases. The In vitro diagnostic offers detection of several diseases, and helps in management and maintenance of diseases related conditions. IVD are reagents, instruments, and systems intended to diagnose various diseases that include determination of the state of health, and also cure, mitigate, treat, or prevent diseases. The Europe IVD market accounted for $19,124 million in 2016, and is estimated to reach $26,623 million by 2023, growing at a CAGR of 4.7% during the analysis period of 2017–2023.The growth of the IVD market in Europe is primarily characterized by the increase in geriatric & amputee population, high incidence of chronic diseases, and growth in investment on hospital infrastructure. Point-of-care testing is widely used in Europe due to the ease of use and convenience. Recently, European Union (EU) regulatory framework for IVD has introduced significant changes to the previous regulatory framework. This updated policy is expected to enable new product launches at a much faster rate as the new EU regulatory authority aims to provide a robust, transparent, and sustainable regulatory framework.The market is segmented on the basis of product type, techniques, application, end user, and country. By product type, the market is categorized into reagents, instruments and software & services. On the basis of techniques, it is categorized into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. Application segment covered in the study includes infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is classified into hospitals, academic and medical schools, point-of-care testing, and others. By geography, it is analyzed across the UK, Germany, France, Spain, Italy, and Rest of Europe.KEY BENEFITS FOR STAKEHOLDERSComprehensive analysis of factors that drive and restrict the growth of the Europe IVD market is provided.The projections in the market are made by studying the current market trends and future market potential for the period in terms of value.Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective marketKey market players within the Europe IVD market are profiled in the market and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the market.Comprehensive analysis of all countries is provided that determines the prevailing opportunities in these countries.KEY MARKET SEGMENTSBy Product TypeReagentsInstrumentsSoftware and ServicesBy TechniquesImmunodiagnosticsEnzyme-Linked Immunosorbent Assay (ELISA)Chemiluminescence Immunoassays (CLIAS)Fluorescence Immunoassays (FIAS)Colorimetric Immunoassays (CIS)Rapid TestsEnzyme-Linked Immunospot Assays (ELISPOT)RadioimmunoassayWestern BlotBlood TestingMolecular DiagnosticsPolymerase Chain Reaction (PCR)Isothermal Nucleic Acid Amplification Technology (INAAT)HybridizationDNA DiagnosticsMicroarraysOthersTissue DiagnosticsClinical ChemistryBasic Metabolic PanelLiver PanelLipid ProfileThyroid Function PanelRenal ProfileElectrolyte PanelSpecialty ChemicalsOther IVD TechniquesBy ApplicationInfectious DiseasesCancerCardiac DiseasesImmune System DisordersNephrological DiseasesGastrointestinal DiseasesOther IndicationsBy End UsersStandalone LaboratoryHospitalsAcademic and Medical SchoolsPoint of Care TestingOthersBy CountryUKGermanyFranceSpainItalyRest of EuropeList of players profiled in the reportThermo Fisher Scientific Inc.Alere Inc.BiomerieuxDanaher CorporationF. Hoffmann-La Roche AGBecton Dickinson and CompanyBio-Rad LaboratoriesBayer AGSysmex CorporationJohnson & JohnsonDownload the full report: https://www.reportbuyer.com/product/5139380
About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com
For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/europe-ivd-market---opportunity-analysis-and-industry-forecast-2017-2023-300549095.html
SOURCE ReportBuyer
